NYTHA Advises Longer Flunixin Withdrawal Time

NYTHA Advises Longer Flunixin Withdrawal Time

The recommended 32-hour withdrawal time is based upon a single intravenous dose of 1 milligram per kilogram.

Photo: Anne M. Eberhardt/The Horse

Saying the current withdrawal time on the books for flunixin meglumine (marketed under the trade name Banamine) could leave New York horsemen and veterinarians vulnerable to positive tests, the New York Thoroughbred Horsemen's Association (NYTHA) is recommending extending the time by an additional eight hours.

In a letter to members and others, the NYTHA said there has been growing concern in recent months that the New York rule with a recommended withdrawal time of 24 hours for flunixin does not provide horsemen and veterinarians with sufficient safe harbor from possible positive tests. The NYTHA is recommending horsemen follow a 32-hour withdrawal time for the non-steroidal anti-inflammatory drug.

The group said its own study, followed by an NYTHA-funded research project with the Racing Medication and Testing Consortium (RMTC), led to the new recommended withdrawal time for flunixin.

The recommended withdrawal time of 32 hours matches the new withdrawal time adopted by the Association of Racing Commissioners International upon recommendation from the RMTC, and implemented as part of a new national uniform medication program (based upon a single intravenous dose of 1 milligram per kilogram).

Originally published on BloodHorse.com.

About the Author

The Blood-Horse Staff

The Blood-Horse is the leading weekly publication devoted to international Thoroughbred racing and breeding. Since 1916, the staff of The Blood-Horse has served the Thoroughbred community with the highest standards of journalistic excellence to provide comprehensive and timely editorial coverage and analysis.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More